Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail - Wikidata - awgldk - TriplyDB

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

http://www.wikidata.org/entity/Q33460799

about

Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis Targeting heart failure with preserved ejection fraction: current status and future prospects A Review of Nebivolol Pharmacology and Clinical Evidence Patient selection in heart failure with preserved ejection fraction clinical trials A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure Varying effects of recommended treatments for heart failure with reduced ejection fraction: meta-analysis of randomized controlled trials in the ESC and ACCF/AHA guidelines The human sympathetic nervous system: its relevance in hypertension and heart failure Time-Dependent Regional Myocardial Strains in Patients with Heart Failure with a Preserved Ejection Fraction.Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial.Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study)Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.Beta-blockers in older patients with heart failure and preserved ejection fraction: class, dosage, and outcomes.Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease.Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure Epidemiology and clinical course of heart failure with preserved ejection fraction Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessons Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry.Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.Comparison of β-blocker effectiveness in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction.Heart failure in elderly: progress in clinical evaluation and therapeutic approach.Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.Nebivolol in chronic heart failure: current evidence and future perspectives.Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.Hypertension 2010: what was new for the cardiologist?β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.Treatment of heart failure with preserved ejection fraction.

P2860

Q21132299-7F6B2ADC-5608-4A8D-8C6A-2DBCB273BD6F Q26752956-D81E3423-6BCE-4690-A6B1-0760B595F6C3 Q26801287-C2603F37-01E9-4ECA-B37B-694D1D0AAEA1 Q27015845-B8203698-33BC-4D9B-AFFF-108E5C7D5400 Q28068618-F281F06F-CC0E-4076-9419-889DCE29A3DD Q28069387-56CD6EA8-BE38-4D59-A5B2-8351D65792C5 Q28264609-6623F892-A85A-4B75-B1F9-8AC871B31989 Q30386839-5EB1DD0C-A2BE-429A-9171-2C8DC08A7A63 Q30534526-C8A23720-1050-4090-A8AD-7A920E4D8235 Q30837563-A6D91E11-5A63-4F97-A5B9-84F63F62682D Q33682749-567CFE58-CF17-43DF-A1E6-85F1F92123D0 Q33791046-F5DF5B94-F653-4142-B6AF-812D6C33B9A8 Q33857564-1CAC949D-DFCC-4343-89F0-DDE21448DB0D Q33885952-69BEA8D6-4452-4913-9305-62D90C75997B Q34020768-9B3BCD69-318F-48DF-BFF9-AE5D5CDBC806 Q34386568-8CB6244B-4A28-4BF9-BDBA-312FA9126CB8 Q34413027-256B96DA-6F1A-4212-8AE3-A07F2B1BF76D Q34528187-4C5196EE-E136-4EB7-98CC-DD9FAF9E15B7 Q34609451-9E5FA8B2-1092-4D3D-960B-6BE676FBD846 Q34664894-F93BC1AF-2E3F-4F2B-A7DC-206A8644168C Q35006600-51265E0A-9B5C-4B13-8212-580DF76D26A3 Q35057999-0DD1D616-7BC9-49B3-80AE-95BF9DCD9689 Q35139959-C53D716B-F575-41E9-8531-C9ED0C1F6871 Q35170235-B7651876-9EDB-49BE-ABFB-C0DF25BC28A6 Q35282590-80B34365-5C4E-4B4D-8E0A-D7DDF0643B8A Q35328760-228F8284-8CDB-4F39-A85C-ACA9E18943FC Q35882942-85F2DD4D-0A56-454C-A5A2-491BCEEAF3E7 Q36042624-2A8AB2DF-5FE0-4E7E-A57E-AF9C0480B81A Q36167458-34FD189C-A04B-47D8-B2F1-B2197B10CF8C Q36707966-46D8C861-4C31-433A-BA4F-925937ABB7B7 Q36918171-2FF65630-76C3-4BC0-A177-85DCDB40CECC Q37001576-4186283D-0958-48EE-B461-D5C30E594BA6 Q37292234-7B6C9D8D-A0A0-4C92-9F45-B109EB4E7FEC Q37312535-2E456E66-2AB0-4246-B458-90335924EC50 Q37390767-529348A1-D1E5-41AC-983F-82328C694F69 Q37716016-A71D23B5-8B6C-4ED8-91CF-7A42A038EAFF Q37725106-F8BDCFC2-9379-4EE3-BDE2-866D98FD1C90 Q37803231-EC3A5142-C48F-42E7-9B88-0A6AD53A8B78 Q37822723-7EE5D514-2018-49F1-9821-9D1EF89260FC Q37848405-3B0BE287-CDF5-41CC-AEBA-6ADFF0F42E79

P2860

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

http://www.wikidata.org/entity/Q33460799

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Beta-blockade with nebivolol i ...... ion in Seniors With Heart Fail

@ast

Beta-blockade with nebivolol i ...... ion in Seniors With Heart Fail

@en

type

label

Beta-blockade with nebivolol i ...... ion in Seniors With Heart Fail

@ast

Beta-blockade with nebivolol i ...... ion in Seniors With Heart Fail

@en

prefLabel

Beta-blockade with nebivolol i ...... ion in Seniors With Heart Fail

@ast

Beta-blockade with nebivolol i ...... ion in Seniors With Heart Fail

@en

P1433

Q33460799-0D26ADD3-392B-4276-8409-60C56A9967CF

P1476

Q33460799-79E9BC1C-FF70-4411-89F4-05CBD2F3728B

P2093

Q33460799-041128D1-5854-4577-996F-06F63E72D83C

Q33460799-0655481A-24C0-404E-BFFA-63504F8B01DE

Q33460799-36B629D8-5B8D-463A-8D42-8CBADCB19A09

Q33460799-549CA4A8-2574-448F-8FAF-893E70B43CD0

Q33460799-B87355CB-64AA-4DA0-9F6F-839294D165EB

Q33460799-E0DBA8B6-FE50-4358-96E9-F839C057D1D1

Q33460799-EE1A2ECD-3E31-4874-95DB-B9E69099C2D3

P304

Q33460799-A2295871-A5AA-4D87-819D-F96F72256DD5

P31

Q33460799-FA082FD1-BB31-4A80-8F74-DE86A8E14C9A

P356

Q33460799-714754E1-2C17-4138-A333-DBB63CD068D5

P407

Q33460799-0002D288-15A5-4FD9-A0B8-CCB5C3849281

P433

Q33460799-9D155E4C-6CB7-4B01-9BA2-F7C3E8A3C6FE

P478

Q33460799-4423B66F-807D-4BE6-9F7E-0C87AF786B77

P50

Q33460799-3FE80C40-0035-400B-ADE3-7D4890692785

Q33460799-4B069767-4EE8-4E02-941E-6BFA4961A582

Q33460799-8B5B5787-7925-475D-BABA-D14774AB5ACB

P577

Q33460799-EB44A64F-AA2D-457E-AF8A-0FC0D154E659

P5875

Q33460799-21B40A68-C934-4F22-B4A4-B8D22C6C68BC

P698

Q33460799-186857C4-F0BC-4255-93C5-89A53C8FCBF7

P921

Q33460799-58FFA928-92E0-41C8-AA2F-FA4D6CE77833

P356

J.JACC.2009.02.046

P1433

Journal of the American College of Cardiology

P1476

Beta-blockade with nebivolol i ...... ion in Seniors With Heart Fail

@en

P2093

Andrew J S Coats

http://www.w3.org/2001/XMLSchema#string

Daphne Babalis

http://www.w3.org/2001/XMLSchema#string

Marcus D Flather

http://www.w3.org/2001/XMLSchema#string

Michael Böhm

http://www.w3.org/2001/XMLSchema#string

Michael Roughton

http://www.w3.org/2001/XMLSchema#string

Philip A Poole-Wilson

http://www.w3.org/2001/XMLSchema#string

SENIORS Investigators

http://www.w3.org/2001/XMLSchema#string

P304

2150-2158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2009.02.046

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Stefan D. Anker

Alain Cohen-Solal

Dirk J van Veldhuisen

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26267677

http://www.w3.org/2001/XMLSchema#string

P698

19497441

http://www.w3.org/2001/XMLSchema#string

P921